Similarly to what has been mentioned for prostate cancer and RCC, abnormal VEGF-A expression can be used as a prognostic marker in bladder cancer as well [81], since VEGF-A expression is higher in deeper and invasive tumors than in superficial and non-invasive ones [82]. This evidence concerns the gene VEGFA and renal cell carcinoma.